Oneness Biotech Co Ltd (4743) — Capital Reinvestment Ratio
Latest as of September 2025:
0.41x
Oneness Biotech Co Ltd (4743) has a Capital Reinvestment Ratio of 0.41x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$14.32 Million) in capital expenditures (NT$5.92 Million). See how much free cash does Oneness Biotech Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.41x
Capex / Operating Cash Flow
Operating Cash Flow
NT$14.32 Million
TWD
Capital Expenditures
NT$5.92 Million
TWD
Data as of
Sep 2025
Most recent filing
Oneness Biotech Co Ltd Capital Reinvestment Ratio (2010–2020)
This chart tracks Oneness Biotech Co Ltd's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Oneness Biotech Co Ltd (2010–2020)
Year-by-year Capital Reinvestment Ratio for Oneness Biotech Co Ltd from 2010 to 2020. For live market cap and broader valuation context, see Oneness Biotech Co Ltd (4743) total market value.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.97x | NT$158.14 Million | NT$153.27 Million | ▲ +151.7% |
| 2012 | 0.39x | NT$24.15 Million | NT$9.30 Million | ▲ +286.2% |
| 2010 | 0.10x | NT$153.25 Million | NT$15.28 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow